Fig. 4From: Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy developmentAssociation between immune subtypes and immunomodulators in GBM. Differences in expression levels of ICP-related genes among GBM immune subtypes in the TCGA cohort (a) and the REMBRANDT cohort (b). Differences in expression levels of ICD-related genes among GBM immune subtypes in the TCGA cohort (c) and the REMBRANDT cohort (d). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001Back to article page